Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Q: When is Aspire Biopharma (NASDAQ:ASBP) presenting at the Sidoti Virtual Investor Conference?

Aspire Biopharma will present on August 20, 2025, at 1:45 PM Eastern .

Q: Who will be presenting for Aspire Biopharma at the Sidoti Conference?

Kraig Higginson , Interim Chief Executive Officer of Aspire Biopharma, will be presenting at the conference.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Aspire Biopharma Holdings (NASDAQ:ASBP), a company developing patent-pending drug and supplement delivery technology, has announced its participation in the upcoming Sidoti Virtual Investor Conference. Interim CEO Kraig Higginson will present on August 20, 2025, at 1:45 PM Eastern.

The company will also host one-on-one meetings with investors on August 20-21, 2025. Investors can access the virtual presentation through Sidoti's registration platform, and a replay will be available on Aspire's investor relations website.

08/14/2025 - 08:00 AM

ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg

One-on-One Meetings

Aspire will also host virtual one-on-ones with investors on Wednesday, August 20 and Thursday, August 21, 2025. To register for the presentation or one-on ones, visit https://sidoti.com/events.

A replay of the presentation will be available on the investor relations section of Aspire's website at https://ir.aspirebiolabs.com/events/

About Aspire Biopharma, Inc.

Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit www.aspirebiolabs.com.

Aspire Biopharma Holdings, Inc.

Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com

SOURCE: Aspire Biopharma Holdings, Inc.

View the original press release on ACCESS Newswire

FAQ

When is Aspire Biopharma (NASDAQ:ASBP) presenting at the Sidoti Virtual Investor Conference?

Aspire Biopharma will present on August 20, 2025, at 1:45 PM Eastern.

Who will be presenting for Aspire Biopharma at the Sidoti Conference?

Kraig Higginson, Interim Chief Executive Officer of Aspire Biopharma, will be presenting at the conference.

How can investors access Aspire Biopharma's Sidoti Conference presentation?

Investors can access the virtual presentation through Sidoti's registration platform at sidoti.com/events, and a replay will be available on Aspire's investor relations website.